Institutional Financing & Revenue Growth Should Set Up SLTK For Big 2018 Returns
ACCESSWIRENovember 15, 2017
Conspicuously, Solis Tek CEO Forchic may have indicated just how big 2018 could be in Monday's press release, saying the proceeds will "...assure our supply chain execution and maintain inventory levels that can meet customer demand..." In the wake of launching a brand new nutrient line and lighting controller, Solis Tek could be lined up for a quality next few months as orders turn into revenue.
What makes 2018 so important? For one, Canada may be on the verge of country-wide cannabis legalization next summer, and Canadian growers are already ramping up in anticipation. Aurora Cannabis Inc (ACBFF) is now up more than 90% this month, fueled by rising revenue and expectations that it can secure a strong position in Quebec's legalized cannabis market. These are Solis Tek's potential customers, and as they continue to grow, it's highly likely that so will Solis Tek.
Most traders and investors are well-aware of the boom in cannabis-focused companies and their stocks. The Viridian Cannabis Stock Index, which tracks the performance of 50 publicly traded cannabis companies, returned a tremendous 236% in 2016 as investors and traders anticipated new cannabis markets coming online after the elections in November, and the index climbed another 35% in the first months of 2017.
Companies like Toronto-traded Canopy Growth Corp (TSX:WEED, OTC PINK:TWMJF), which grows legal marijuana for the Canadian medical market, climbed almost 200% in 2016 and 122% so far in 2017. The company has done an amazing job of monetizing their business in the last two years, delivering almost $40 million in sales and a massive partnership with Constellation Brands, Inc.(STZ) just last month.
But many cannabis companies, and their shares, haven't delivered for investors in the same way. The unfortunate thing is the state of some of these small companies' Income Statements - abysmal. Zero-to-no revenue with high expenses and a path to revenue growth based only on the "hope" that recreational and medical marijuana go mainstream, and they get a chunk of the business. Finding cannabis companies that are executing well isn't easy, but SLTK is one of the rare companies generating sales, and with bright prospects for 2018.
The problem isn't that many small companies aren't real - many of them have experienced management teams and may have bright futures. It's that investors aren't seeing the results they'd hoped to see--rapidly--since legalization in key states like California. In other words, the excitement of 2016 hasn't turned into measurable revenue and stock performance in 2017.
State laws are lining up in the right direction, with almost half of the country having legalized cannabis in one form or another. Legal marijuana generated $7 billion in the U.S. last year, which is expected to grow to $25 billion by 2020, and $50 possibly billion by 2026.
So what's the disconnect? Most of these sales aren't trickling down to the few public companies going after this growing but highly competitive market.
The Market Is Real, But It May Not Be Where You Thought...
What most investors don't realize is that while it may be sexy to invest in companies that grow, process, or sell marijuana, the reality is that the much of the smart money has looked elsewhere, to "Ancillary" businesses, to reduce risk and find big upside.
That is, besides the more established growers, sophisticated funds gravitate towards companies that service or supply the growers, rather than own the growers themselves.
The data speaks for itself. According to Viridian Capital Advisors, 70% of the M&A and capital raises/financings in October in the cannabis space occurred around companies that do NOT touch the plant - so-called "Ancillary Products and Services."
In reality, the smart money is participating in deals around peripheral companies, like those that provide services or products TO the companies that "touch the plant."
Take note of what Scott's Miracle-Gro (SMG) has poured into their Hawthorne subsidiary in the last few years - almost $300 mln in investment dollars for acquisitions and development. Grow lighting, for instance, isn't where most cannabis investors would think to look first, but it's an incredibly lucrative space. According to Grand View Research, the global cannabis grow light market is expected to reach $8.6 billion by 2025! Case in point, Scott's acquired a 75% interest in European lighting company Gavita for $136.2 mln in 2016, valuing this non-public company at nearly $200 mln based on their lighting products alone.
Similar SLTK Is Executing, Ready To Rocket With Financing Complete
Solis Tek, meanwhile, is one of THE premier grow-light distributors in the U.S., generating $7.34 million in the first 9 months of this year, and a compelling 12% growth over the same period last year. Solis Tek is one of the few small-cap cannabis companies with a solid business and growing sales - and they don't even touch the plant.
Grow lights are critical to facilitating healthier plants throughout the growth cycle, and Solis Tek has been selected as one of THE top U.S. providers on multiple occasions and by multiple third parties: an independent test of six lighting products conducted by Light Laboratory Inc confirmed that Solis Tek's digital lighting solutions scored highest in terms of overall value for cultivators; and they won the DOPE Industry Awards for "Best Lighting Company".
The company has been making great headway in the industry for the last few years, and with the recent launch of Terpenez, their own nutrient product for cannabis growers, and a second nutrient to follow imminently, the company is positioned for a possibly huge 2018 as more and more states legalize regional cannabis production. This week the company completed an institutionally-supported financing with one institution alone buying $1.75 mln of stock, according to the company. This strong financing has the potential to be non-dilutive, in fact, as much of the total $2.5 mln raised is structured as convertible debt.
What could this mean? First, management has been signaling that demand for recently launched products is significant, and this capital infusion will be used for inventory preparation. Second, preparing and launching their first and second nutrient formulations, the first of which is called Terpenez, puts Solis Tek into an entirely new and high-margin vertical; they're suite of services should be that much more attractive to larger companies like Canopy Growth or Aurora Cannabis. Finally, improving the ownership structure with institutional backers offers validation for other public investors, and SLTK could be read for primetime in 2018.
The real kicker with SLTK is how incentivized management is to execute: CEO Dennis Forchic owns 15% of the company, and insiders combined own about 70% of the company, demonstrating these executives' confidence in the business. As Canada and more states bring marijuana sales online in the next year, SLTK has the right recipe for huge growth.
About One Equity Stocks
One Equity Stocks is a leading provider of research on publicly traded emerging growth companies. Our team is comprised of sophisticated financial professionals that strive to find the companies and management teams that will outperform the market and deliver investment returns to our subscribers. We are not a licensed broker-dealer and do not publish investment advice and remind readers that investing involves considerable risk. One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. One Equity Stocks is a for-profit business and is usually compensated for coverage of issuers. In the case of SLTK, we are reimbursed for actual costs of this distribution and have received 100,000 shares of restricted stock for Business Development, Capital Markets and Research Services. Readers should always assume that we will sell some or all of our position as soon as the 180 day anniversary of the stock's issuance date. Please contact us at info@investorclick.net for additional information or to subscribe to our intelligence service.
SOURCE: One Equity Stocks
ACCESSWIRENovember 15, 2017
- In the cannabis industry, ancillary products and services have attracted significant investment, accounting for the majority of recent financings and M&A according to Viridian Capital
- The smart money is in. Institutional financing and strong third quarter results for Solis Tek (SLTK) indicate potentially big 2018 with new product lines and inventory prep ahead of Canadian legalization decision next summer
Conspicuously, Solis Tek CEO Forchic may have indicated just how big 2018 could be in Monday's press release, saying the proceeds will "...assure our supply chain execution and maintain inventory levels that can meet customer demand..." In the wake of launching a brand new nutrient line and lighting controller, Solis Tek could be lined up for a quality next few months as orders turn into revenue.
What makes 2018 so important? For one, Canada may be on the verge of country-wide cannabis legalization next summer, and Canadian growers are already ramping up in anticipation. Aurora Cannabis Inc (ACBFF) is now up more than 90% this month, fueled by rising revenue and expectations that it can secure a strong position in Quebec's legalized cannabis market. These are Solis Tek's potential customers, and as they continue to grow, it's highly likely that so will Solis Tek.
Most traders and investors are well-aware of the boom in cannabis-focused companies and their stocks. The Viridian Cannabis Stock Index, which tracks the performance of 50 publicly traded cannabis companies, returned a tremendous 236% in 2016 as investors and traders anticipated new cannabis markets coming online after the elections in November, and the index climbed another 35% in the first months of 2017.
Companies like Toronto-traded Canopy Growth Corp (TSX:WEED, OTC PINK:TWMJF), which grows legal marijuana for the Canadian medical market, climbed almost 200% in 2016 and 122% so far in 2017. The company has done an amazing job of monetizing their business in the last two years, delivering almost $40 million in sales and a massive partnership with Constellation Brands, Inc.(STZ) just last month.
But many cannabis companies, and their shares, haven't delivered for investors in the same way. The unfortunate thing is the state of some of these small companies' Income Statements - abysmal. Zero-to-no revenue with high expenses and a path to revenue growth based only on the "hope" that recreational and medical marijuana go mainstream, and they get a chunk of the business. Finding cannabis companies that are executing well isn't easy, but SLTK is one of the rare companies generating sales, and with bright prospects for 2018.
The problem isn't that many small companies aren't real - many of them have experienced management teams and may have bright futures. It's that investors aren't seeing the results they'd hoped to see--rapidly--since legalization in key states like California. In other words, the excitement of 2016 hasn't turned into measurable revenue and stock performance in 2017.
State laws are lining up in the right direction, with almost half of the country having legalized cannabis in one form or another. Legal marijuana generated $7 billion in the U.S. last year, which is expected to grow to $25 billion by 2020, and $50 possibly billion by 2026.
So what's the disconnect? Most of these sales aren't trickling down to the few public companies going after this growing but highly competitive market.
The Market Is Real, But It May Not Be Where You Thought...
What most investors don't realize is that while it may be sexy to invest in companies that grow, process, or sell marijuana, the reality is that the much of the smart money has looked elsewhere, to "Ancillary" businesses, to reduce risk and find big upside.
That is, besides the more established growers, sophisticated funds gravitate towards companies that service or supply the growers, rather than own the growers themselves.
The data speaks for itself. According to Viridian Capital Advisors, 70% of the M&A and capital raises/financings in October in the cannabis space occurred around companies that do NOT touch the plant - so-called "Ancillary Products and Services."
In reality, the smart money is participating in deals around peripheral companies, like those that provide services or products TO the companies that "touch the plant."
Take note of what Scott's Miracle-Gro (SMG) has poured into their Hawthorne subsidiary in the last few years - almost $300 mln in investment dollars for acquisitions and development. Grow lighting, for instance, isn't where most cannabis investors would think to look first, but it's an incredibly lucrative space. According to Grand View Research, the global cannabis grow light market is expected to reach $8.6 billion by 2025! Case in point, Scott's acquired a 75% interest in European lighting company Gavita for $136.2 mln in 2016, valuing this non-public company at nearly $200 mln based on their lighting products alone.
Similar SLTK Is Executing, Ready To Rocket With Financing Complete
Solis Tek, meanwhile, is one of THE premier grow-light distributors in the U.S., generating $7.34 million in the first 9 months of this year, and a compelling 12% growth over the same period last year. Solis Tek is one of the few small-cap cannabis companies with a solid business and growing sales - and they don't even touch the plant.
Grow lights are critical to facilitating healthier plants throughout the growth cycle, and Solis Tek has been selected as one of THE top U.S. providers on multiple occasions and by multiple third parties: an independent test of six lighting products conducted by Light Laboratory Inc confirmed that Solis Tek's digital lighting solutions scored highest in terms of overall value for cultivators; and they won the DOPE Industry Awards for "Best Lighting Company".
The company has been making great headway in the industry for the last few years, and with the recent launch of Terpenez, their own nutrient product for cannabis growers, and a second nutrient to follow imminently, the company is positioned for a possibly huge 2018 as more and more states legalize regional cannabis production. This week the company completed an institutionally-supported financing with one institution alone buying $1.75 mln of stock, according to the company. This strong financing has the potential to be non-dilutive, in fact, as much of the total $2.5 mln raised is structured as convertible debt.
What could this mean? First, management has been signaling that demand for recently launched products is significant, and this capital infusion will be used for inventory preparation. Second, preparing and launching their first and second nutrient formulations, the first of which is called Terpenez, puts Solis Tek into an entirely new and high-margin vertical; they're suite of services should be that much more attractive to larger companies like Canopy Growth or Aurora Cannabis. Finally, improving the ownership structure with institutional backers offers validation for other public investors, and SLTK could be read for primetime in 2018.
The real kicker with SLTK is how incentivized management is to execute: CEO Dennis Forchic owns 15% of the company, and insiders combined own about 70% of the company, demonstrating these executives' confidence in the business. As Canada and more states bring marijuana sales online in the next year, SLTK has the right recipe for huge growth.
About One Equity Stocks
One Equity Stocks is a leading provider of research on publicly traded emerging growth companies. Our team is comprised of sophisticated financial professionals that strive to find the companies and management teams that will outperform the market and deliver investment returns to our subscribers. We are not a licensed broker-dealer and do not publish investment advice and remind readers that investing involves considerable risk. One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. One Equity Stocks is a for-profit business and is usually compensated for coverage of issuers. In the case of SLTK, we are reimbursed for actual costs of this distribution and have received 100,000 shares of restricted stock for Business Development, Capital Markets and Research Services. Readers should always assume that we will sell some or all of our position as soon as the 180 day anniversary of the stock's issuance date. Please contact us at info@investorclick.net for additional information or to subscribe to our intelligence service.
SOURCE: One Equity Stocks
SLTK Initiating coverage of Solis Tek, Inc. with a Speculative Buy rating and twelve-month price target of $3.00 pershare
http://www.taglichbrothers.com/companyreports/solis_tek/solis_tek-11202017.pdf
http://www.taglichbrothers.com/companyreports/solis_tek/solis_tek-11202017.pdf
Big breakout on SLTK since the funding . Looking at some acquisitions that if completed at good prices could, drive this company over 5 easily in 2018 IMO
email this chart
printer-friendly format
[h=1]Solis Tek, Inc. Makes the Most Advanced Digital Lighting Controller Available for Cannabis Growers![/h]Sponsored
Grow | Submitted by
Daniel Cheine November 27, 2017 | United States
[FONT="]There are over 2,000 wholesale cannabis cultivation businesses in the United States. The average commercial grower allocates around 25% of the total startup cost towards acquiring a lighting system. Beyond just the massive upfront cost, choosing the wrong lighting solution can decrease yield and impact the quality of the product.[/FONT]
[FONT="]Over the past several years, there have been significant advancements in lighting technology. One such advancement is the controllability of lights. Controllers provide commercial growers with control over light cycles and temperature to aid them in improving quality and yield.[/FONT]
[FONT="]Solis Tek, a leader in research, design, development, and manufacturing of lighting solutions, has taken the concept of controllability one step further. The company’s Digital Lighting Controller for cultivation businesses is already making waves in the market.[/FONT]
[FONT="]Solis Tek is no stranger to innovation. Leading commercial growers have been utilizing the Company’s HID lights for many years. The company is credited with developing several innovations that are now considered the standard in the industry including Ignition Control, which is designed to prevent surges and breaker overloads by igniting lamps one at a time based on load stability, and SenseSmart, which is a pre-ignition diagnostic check.[/FONT]
[FONT="]The company also pioneered the “light diet”, which is now utilized among many top commercial cannabis growers and is a scientific approach to creating lighting which mimics the sun in the more controlled environments of green houses and indoor cultivation facilities. Solis Tek's unique four spectrum "light diet" targets specific growth cycles and replicates the different seasons of Mother Nature, where the plants make use of natural light in different ways.[/FONT]
[FONT="]Solis Tek’s new Digital controller takes this “light diet” approach to the next level. Giving cultivators even more control over their lighting environment. In fact, the Controller enables cultivators to manage up to 300 lights simultaneously, and manage a number of light cycles while being located in different places.[/FONT]
[FONT="]
[/FONT]
[FONT="]Here are some additional features the Solis Tek Digital Lighting Controller offers:[/FONT]
Upvote
Grow | Submitted by
Daniel Cheine November 27, 2017 | United States
[FONT="]There are over 2,000 wholesale cannabis cultivation businesses in the United States. The average commercial grower allocates around 25% of the total startup cost towards acquiring a lighting system. Beyond just the massive upfront cost, choosing the wrong lighting solution can decrease yield and impact the quality of the product.[/FONT]
[FONT="]Over the past several years, there have been significant advancements in lighting technology. One such advancement is the controllability of lights. Controllers provide commercial growers with control over light cycles and temperature to aid them in improving quality and yield.[/FONT]
[FONT="]Solis Tek, a leader in research, design, development, and manufacturing of lighting solutions, has taken the concept of controllability one step further. The company’s Digital Lighting Controller for cultivation businesses is already making waves in the market.[/FONT]
[FONT="]Solis Tek is no stranger to innovation. Leading commercial growers have been utilizing the Company’s HID lights for many years. The company is credited with developing several innovations that are now considered the standard in the industry including Ignition Control, which is designed to prevent surges and breaker overloads by igniting lamps one at a time based on load stability, and SenseSmart, which is a pre-ignition diagnostic check.[/FONT]
[FONT="]The company also pioneered the “light diet”, which is now utilized among many top commercial cannabis growers and is a scientific approach to creating lighting which mimics the sun in the more controlled environments of green houses and indoor cultivation facilities. Solis Tek's unique four spectrum "light diet" targets specific growth cycles and replicates the different seasons of Mother Nature, where the plants make use of natural light in different ways.[/FONT]
[FONT="]Solis Tek’s new Digital controller takes this “light diet” approach to the next level. Giving cultivators even more control over their lighting environment. In fact, the Controller enables cultivators to manage up to 300 lights simultaneously, and manage a number of light cycles while being located in different places.[/FONT]
[FONT="]
[FONT="]Here are some additional features the Solis Tek Digital Lighting Controller offers:[/FONT]
- Precise canopy temperature monitoring that can be connected to up to 25 sensors
- Work with up to 300 lights at once and manage multiple lighting cycles
- Customized sunrise and sunset options, enabling growers to run lighting cycles based on their plants’ unique needs
- Data analytics log to track a garden’s events and faults/warnings
- High-temperature auto dim and shut off that automatically reacts based on room temperature
- Energy efficient cloud cover simulation to mimic the true nature of the sun when full intensity light is not needed
- Solis Tek’s Digital Lighting Controller is simple, durable, lightweight, and compact
[FONT="]“The controller provides a level of versatility not found in any other product on the market, specific to cannabis or others crops. For example, if a grower wishes to run their lights on a 22-hour cycle versus a 24-hour cycle - that is possible. Or, if their plants do not need a full intensity light during a particular period, they can create an environment which mimics cloud cover for a specific period of time.”[/FONT]
[FONT="]In all, Solis Tek’s Digital Lighting Controller is a revolutionary product developed by an innovative team of professionals who care about providing a large ROI to their customers. Customer satisfaction is also of utmost importance to Solis Tek, and that is why Solis Tek has a customer friendly support team to help a cultivator with any questions, and will be glad to give them a free consultation. They can contact the Solis Tek team via phone (888) 998-8881 or via e-mail info@solis-tek.com.[/FONT]
Upvote
[FONT="][h=1]This Unknown Cannabis Stock Could Have Big Upside as Wall Street Takes Notice[/h]
ACCESSWIRENovember 29, 2017
[/FONT]
[FONT="]With First Investment Bank Analyst Report, Wall St Reveals they're Taking this Revenue-generating Cannabis Company Seriously
NEW YORK, NY / ACCESSWIRE / November 29, 2017 / Little Solis Tek, Inc (OTCMKTS:SLTK) might finally be getting some attention from Wall Street. This month, the company received institutional research coverage from the investment bank and brokerage firm Taglich Brothers, with a “Speculative Buy” rating and twelve-month price target of $3.00 per share. Shares in this small cannabis company are gaining in daily volume and the stock is climbing as investors start to take notice of this company's market capitalization and under-the-radar status.
Even with their conservative financial modeling assumptions, the research analysts at Taglich cite the potential for SLTK to double within 12 months. The Taglich Brothers report can be found at http://www.taglichbrothers.com/equityuniverse/solis_tek.php.
Nutrient Line Launching With High Margins, Big Growth Potential
With the addition to Solis Tek's portfolio of the new nutrient product Terpenez-designed as a new class of horticultural products aimed at enhancing cannabis aromata and intensity-the company is opening a new revenue stream with significantly higher gross margins than other products. Comparisons to similar products in the agriculture industry suggest gross margins for Terpenez and SLTK's soon-to-be-launched follow-ons of around 70 to 80%. Compared to margins on the company's revenue generating and award-winning lighting products of 30 to 40%, Solis Tek's new nutrient line could mean big things for the small company.
With this launch, and continued expansion of the company's lighting products, the company could be setting up for positive cash flows from operations in 2018, according to the Taglich Report. This would be a rare and noteworthy occurrence for a small company, especially in the highly volatile world of cannabis companies, and this kind of performance could make SLTK highly attractive to both larger companies and investors.
Just take a look at the success at Scotts Miracle-Gro (SMG), where their hydroponics-focused subsidiary Hawthorne has been a booming success since launching just a few years ago. This new business segment is all the company's management talks about recently, and it's obvious why...Hawthorne sales increased 137% to $287.2 million in the company's fiscal 2017 due to some smart acquisitions, and organic volume growth at Hawthorne was an astounding 20% for the year!
Stocks Move On Changes In Perception
Publicly traded stocks can move when investor perceptions about the future change. Case in point, the move from niche to mainstream for Bitcoin and other cryptocurrencies. Marathon Patent Group, Inc. (MARA) is the prime example, with a 640% price appreciation in one week's time following the company's acquisition of a bitcoin mining service. The perceived future value changed as investors realized the potential for this bitcoin mining operation to pay off. Similarly, Cerecor Inc (CERC) rallied 50% this week in the followup to news that the company would be acquiring TRx Pharmaceuticals, a specialty pharmaceutical company that has two U.S. FDA approved drugs on the market already.
With Wall Street starting to pay attention, it makes sense that main street investors are doing the same.
About One Equity Stocks
One Equity Stocks is a leading provider of research on publicly traded emerging growth companies. Our team is comprised of sophisticated financial professionals that strive to find the companies and management teams that will outperform the market and deliver investment returns to our subscribers. We are not a licensed broker-dealer and do not publish investment advice and remind readers that investing involves considerable risk. One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. One Equity Stocks is a for-profit business and is usually compensated for coverage of issuers. In the case of SLTK, we are reimbursed for actual costs of this distribution and have received 100,000 shares of restricted stock for Business Development, Capital Markets and Research Services. Readers should always assume that we will sell some or all of our position on the 180 day anniversary of the stock's issuance date. Please contact us at info@investorclick.net for additional information or to subscribe to our intelligence service.
SOURCE: One Equity Stocks, LLC
[/FONT]
ACCESSWIRENovember 29, 2017
[/FONT]
[FONT="]With First Investment Bank Analyst Report, Wall St Reveals they're Taking this Revenue-generating Cannabis Company Seriously
NEW YORK, NY / ACCESSWIRE / November 29, 2017 / Little Solis Tek, Inc (OTCMKTS:SLTK) might finally be getting some attention from Wall Street. This month, the company received institutional research coverage from the investment bank and brokerage firm Taglich Brothers, with a “Speculative Buy” rating and twelve-month price target of $3.00 per share. Shares in this small cannabis company are gaining in daily volume and the stock is climbing as investors start to take notice of this company's market capitalization and under-the-radar status.
Even with their conservative financial modeling assumptions, the research analysts at Taglich cite the potential for SLTK to double within 12 months. The Taglich Brothers report can be found at http://www.taglichbrothers.com/equityuniverse/solis_tek.php.
Nutrient Line Launching With High Margins, Big Growth Potential
With the addition to Solis Tek's portfolio of the new nutrient product Terpenez-designed as a new class of horticultural products aimed at enhancing cannabis aromata and intensity-the company is opening a new revenue stream with significantly higher gross margins than other products. Comparisons to similar products in the agriculture industry suggest gross margins for Terpenez and SLTK's soon-to-be-launched follow-ons of around 70 to 80%. Compared to margins on the company's revenue generating and award-winning lighting products of 30 to 40%, Solis Tek's new nutrient line could mean big things for the small company.
With this launch, and continued expansion of the company's lighting products, the company could be setting up for positive cash flows from operations in 2018, according to the Taglich Report. This would be a rare and noteworthy occurrence for a small company, especially in the highly volatile world of cannabis companies, and this kind of performance could make SLTK highly attractive to both larger companies and investors.
Just take a look at the success at Scotts Miracle-Gro (SMG), where their hydroponics-focused subsidiary Hawthorne has been a booming success since launching just a few years ago. This new business segment is all the company's management talks about recently, and it's obvious why...Hawthorne sales increased 137% to $287.2 million in the company's fiscal 2017 due to some smart acquisitions, and organic volume growth at Hawthorne was an astounding 20% for the year!
Stocks Move On Changes In Perception
Publicly traded stocks can move when investor perceptions about the future change. Case in point, the move from niche to mainstream for Bitcoin and other cryptocurrencies. Marathon Patent Group, Inc. (MARA) is the prime example, with a 640% price appreciation in one week's time following the company's acquisition of a bitcoin mining service. The perceived future value changed as investors realized the potential for this bitcoin mining operation to pay off. Similarly, Cerecor Inc (CERC) rallied 50% this week in the followup to news that the company would be acquiring TRx Pharmaceuticals, a specialty pharmaceutical company that has two U.S. FDA approved drugs on the market already.
With Wall Street starting to pay attention, it makes sense that main street investors are doing the same.
About One Equity Stocks
One Equity Stocks is a leading provider of research on publicly traded emerging growth companies. Our team is comprised of sophisticated financial professionals that strive to find the companies and management teams that will outperform the market and deliver investment returns to our subscribers. We are not a licensed broker-dealer and do not publish investment advice and remind readers that investing involves considerable risk. One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. One Equity Stocks is a for-profit business and is usually compensated for coverage of issuers. In the case of SLTK, we are reimbursed for actual costs of this distribution and have received 100,000 shares of restricted stock for Business Development, Capital Markets and Research Services. Readers should always assume that we will sell some or all of our position on the 180 day anniversary of the stock's issuance date. Please contact us at info@investorclick.net for additional information or to subscribe to our intelligence service.
SOURCE: One Equity Stocks, LLC
[/FONT]
[h=2]Solis Tek Inc : Solis Tek to Present at the 10th Annual LD Micro Main Event on December 6th[/h][FONT="]
[/FONT]
[FONT="]11/29/2017 | 10:10 pm[/FONT]
[FONT="]Alan Lien, Chairman and Co-Founder, to Also Participate in a Panel Discussion On the Emergent Cannabis Industry On December 6
CARSON, CA / ACCESSWIRE / November 29, 2017 / Solis Tek (OTCQB: SLTK) ("Solis Tek" or "Company"), a vertically integrated technology innovator, developer, manufacturer, and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today announced that its Chairman and Co-Founder, Alan Lien, and Chief Executive Officer, Dennis Forchic, will present at the LD Micro Conference on December 6, 2017 at 9:00AM PST / 12:00PM EST at the Luxe Sunset Bel Air Hotel in Los Angeles, California.
The Corporate Presentation will be Webcast at http://wsw.com/webcast/ldmicro13/sltk/. Mr. Lien will also participate in a panel discussion on the future of the cannabis industry on December 6, 2017, at 6:30PM PST.
The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinate evening events.
To learn more about the event, please visit: http://www.ldmicro.com/events.
[/FONT]
|
|
|
|
|
[/FONT]
[FONT="]11/29/2017 | 10:10 pm[/FONT]
[FONT="]Alan Lien, Chairman and Co-Founder, to Also Participate in a Panel Discussion On the Emergent Cannabis Industry On December 6
CARSON, CA / ACCESSWIRE / November 29, 2017 / Solis Tek (OTCQB: SLTK) ("Solis Tek" or "Company"), a vertically integrated technology innovator, developer, manufacturer, and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today announced that its Chairman and Co-Founder, Alan Lien, and Chief Executive Officer, Dennis Forchic, will present at the LD Micro Conference on December 6, 2017 at 9:00AM PST / 12:00PM EST at the Luxe Sunset Bel Air Hotel in Los Angeles, California.
The Corporate Presentation will be Webcast at http://wsw.com/webcast/ldmicro13/sltk/. Mr. Lien will also participate in a panel discussion on the future of the cannabis industry on December 6, 2017, at 6:30PM PST.
The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinate evening events.
To learn more about the event, please visit: http://www.ldmicro.com/events.
[/FONT]
[FONT="][h=1]Here’s Why Recent GBLX Price Action Could Signal Big Upside for Solis Tek (SLTK)[/h]
ACCESSWIREDecember 11, 2017
[/FONT]
[FONT="]
GB Sciences' Production Yield Bodes Well For SLTK
GB Sciences (GBLX) has been on a tear over the last few weeks as investors and traders realize that the small company's cannabis cultivation is finally paying off with revenue. GBLX sold their first cannabis harvest in July, with a yield of 133 pounds of product from 45 grow lights. Now, the company just announced that their October revenue was ahead of expectations, and the company is yielding about 2x the industry norm from their in-house cultivation efforts.
What most investors don't realize, however, is that another publicly traded company, Solis Tek, Inc. supplies GBLX's high-tech grow lights and ballasts, and even growing nutrients. We know that GB Sciences is a customer of Solis Tek, and the fact that the company is already out-producing industry peers speaks volumes to the quality of Solis Tek lighting products. GB Sciences COO Kevin Kuethe said earlier this year, "We have been a Solis Tek lighting customer for years and added the Terpenez product to our grow process because we always recognized their focus on innovation specific to cannabis."
GB Sciences has revealed that their production is twice what the industry expects to get - and this could be attributable to Solis Tek's lights and nutrient additions. SLTK has already received the prestigious "Best Lighting Company of the Year" award from Dope Magazine, and the company's lights outperformed numerous competitors in a recent independent head-to-head laboratory test.
Further, Solis Tek introduced their own nutrient line this June, and GB Sciences is already a customer according to the company. Terpenez, Solis Tek's first product, may be significantly enhancing the GBLX plants already.
Take special note of this - GB Sciences is already using Solis Tek's grow lights, and the company was operating at 200 grow lights in October. This was only 30% of their expected final capacity after further build out of their growing facility is completed. This infrastructure expansion could likewise be significant for SLTK if GB Sciences continues to utilize Solis Tek lighting fixtures and infrastructure. That could be a meaningful revenue stream alone.
Valuation Reasonable, Could Be Set For More Upside in 2018
With these kinds of yields pointing to significant growth potential, Solis Tek's current market valuation appears low. Recently, investment firm Taglich Brothers initiated on this undiscovered company with a $3.00 12-month price target based on conservative revenue growth in 2018 to $11.7 million. Shockingly, other cannabis companies are valued at significant multiples of their revenue, like Aurora Cannabis Inc. (ACBFF), which is currently marked at $2.4 billion in market capitalization based on a sales run rate of about $33 mln, or an 85x Price/Sales ratio. The valuations at growing, quality cannabis companies is impressive, and it may make sense - a growth industry with big upside like cannabis.
The excitement of 2014 and 2015 around cannabis companies is turning into reality now as small companies begin generating sales, and with excellent proof of product concept for Solis Tek, 2018 could be a big year for the small company. With Taglich Brothers conservatively targeting 100% of possible upside into 2018, and other companies trading at 40 to 90X their sales, SLTK could easily be worth multiples of where it trades.
Of course, risks exist with small-cap companies. Solis Tek has to execute well in a space that could see new, large competitors, and there are still regulatory hurdles for the cannabis industry... the federal government is still on the fence about the future of marijuana.
Nevertheless, SLTK has grown revenue over the last few years and their products are being used by growing cultivators, with good proof of concept. 2018 could prove fruitful.
[/FONT]
ACCESSWIREDecember 11, 2017
[/FONT]
[FONT="]
- SLTK products may be improving yield and production for cannabis cultivators, by as much as 2x the industry norm, according to one public company.
- As a result, revenue could be set to take off in 2018, and as cannabis cultivation goes mainstream. Reason to believe SLTK undervalued by 50% to 100%.
GB Sciences' Production Yield Bodes Well For SLTK
GB Sciences (GBLX) has been on a tear over the last few weeks as investors and traders realize that the small company's cannabis cultivation is finally paying off with revenue. GBLX sold their first cannabis harvest in July, with a yield of 133 pounds of product from 45 grow lights. Now, the company just announced that their October revenue was ahead of expectations, and the company is yielding about 2x the industry norm from their in-house cultivation efforts.
What most investors don't realize, however, is that another publicly traded company, Solis Tek, Inc. supplies GBLX's high-tech grow lights and ballasts, and even growing nutrients. We know that GB Sciences is a customer of Solis Tek, and the fact that the company is already out-producing industry peers speaks volumes to the quality of Solis Tek lighting products. GB Sciences COO Kevin Kuethe said earlier this year, "We have been a Solis Tek lighting customer for years and added the Terpenez product to our grow process because we always recognized their focus on innovation specific to cannabis."
GB Sciences has revealed that their production is twice what the industry expects to get - and this could be attributable to Solis Tek's lights and nutrient additions. SLTK has already received the prestigious "Best Lighting Company of the Year" award from Dope Magazine, and the company's lights outperformed numerous competitors in a recent independent head-to-head laboratory test.
Further, Solis Tek introduced their own nutrient line this June, and GB Sciences is already a customer according to the company. Terpenez, Solis Tek's first product, may be significantly enhancing the GBLX plants already.
Take special note of this - GB Sciences is already using Solis Tek's grow lights, and the company was operating at 200 grow lights in October. This was only 30% of their expected final capacity after further build out of their growing facility is completed. This infrastructure expansion could likewise be significant for SLTK if GB Sciences continues to utilize Solis Tek lighting fixtures and infrastructure. That could be a meaningful revenue stream alone.
Valuation Reasonable, Could Be Set For More Upside in 2018
With these kinds of yields pointing to significant growth potential, Solis Tek's current market valuation appears low. Recently, investment firm Taglich Brothers initiated on this undiscovered company with a $3.00 12-month price target based on conservative revenue growth in 2018 to $11.7 million. Shockingly, other cannabis companies are valued at significant multiples of their revenue, like Aurora Cannabis Inc. (ACBFF), which is currently marked at $2.4 billion in market capitalization based on a sales run rate of about $33 mln, or an 85x Price/Sales ratio. The valuations at growing, quality cannabis companies is impressive, and it may make sense - a growth industry with big upside like cannabis.
The excitement of 2014 and 2015 around cannabis companies is turning into reality now as small companies begin generating sales, and with excellent proof of product concept for Solis Tek, 2018 could be a big year for the small company. With Taglich Brothers conservatively targeting 100% of possible upside into 2018, and other companies trading at 40 to 90X their sales, SLTK could easily be worth multiples of where it trades.
Of course, risks exist with small-cap companies. Solis Tek has to execute well in a space that could see new, large competitors, and there are still regulatory hurdles for the cannabis industry... the federal government is still on the fence about the future of marijuana.
Nevertheless, SLTK has grown revenue over the last few years and their products are being used by growing cultivators, with good proof of concept. 2018 could prove fruitful.
[/FONT]
[h=1]Solis Tek Applauds California Pesticide Ban for Cannabis Cultivation[/h]
PRESS RELEASE Marketwired
[COLOR=#9B9B9B !important]Jan. 22, 2018, 08:00 AM
CARSON, CA--(Marketwired - January 22, 2018) - Solis Tek Inc. (OTCQB: SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S, today commented on the California Bureau of Medical Cannabis Regulation's new regulations announced on January 1, 2018, banning the use of a long list of pesticides in cannabis cultivation for medical and adult-use industries. This list represents the most stringent in the country to protect users from ingesting cannabis with harsh chemicals, heavy metals and other properties.
"Solis Tek applauds the California Bureau of Medical Cannabis Regulation and encourages other governing bodies in states with adult- and medical-use laws in place to take the same responsible look at how flower is being cultivated with an eye toward protecting consumers," said Dennis G. Forchic, Chief Executive Officer of Solis Tek.
Mr. Forchic continued, "Having served this industry for nearly a decade, Solis Tek recognizes there is a better way for cultivators to increase yield, protect their crops, enhance their product and ultimately grow healthier plants. This is possible using all-natural products made with organic compounds that are devoid of any banned pesticides, animal by-products, heavy metals, chemicals, or strong odors. These are the types of products that Solis Tek is committed to creating to serve the growing cannabis sector, which is projected to reach $3.7 billion in 2018 in California alone."
"In response to welcomed changes in regulations in various states like that of California and the anticipated tightening of regulations as more states legalize cannabis, our Zelda Horticulture division is developing rigorously tested, all-natural products that provide new and alternative solutions to many of the banned products which have been previously utilized by cannabis cultivators. For example, our first product, Terpenez, provides a safe, effective and regulatory-compliant solution for growers in legal markets both in the U.S. and internationally to enhance their plants' terpene profile," Mr. Forchic added.
Mr. Forchic concluded, "As a response to the new California ban, Solis Tek is aggressively targeting the hydroponic stores in the Golden state, most of which carry our lighting product solutions, that now are replacing banned products on their shelf. Retailers and commercial growers alike have made clear their desire for Solis Tek's products under development, in beta testing, and nearing national launch, all of which contain NONE of the California banned products."
To be added to the Solis Tek email distribution list, please email rel="nofollow">SLTK@kcsa.com with 'SLTK' in the subject line.
About Solis Tek
Solis Tek Inc, parent company of wholly owned subsidiaries Solis Tek Digital Lighting and Zelda Horticulture, is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. In late 2017, Solis Tek introduced Zelda Horticulture, an all-natural, heavy metals free, nutrient line. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, http://solis-tek.com.http://markets.businessinsider.com/...icide-Ban-for-Cannabis-Cultivation-1013590577
[/COLOR]
PRESS RELEASE Marketwired
[COLOR=#9B9B9B !important]Jan. 22, 2018, 08:00 AM
CARSON, CA--(Marketwired - January 22, 2018) - Solis Tek Inc. (OTCQB: SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S, today commented on the California Bureau of Medical Cannabis Regulation's new regulations announced on January 1, 2018, banning the use of a long list of pesticides in cannabis cultivation for medical and adult-use industries. This list represents the most stringent in the country to protect users from ingesting cannabis with harsh chemicals, heavy metals and other properties.
"Solis Tek applauds the California Bureau of Medical Cannabis Regulation and encourages other governing bodies in states with adult- and medical-use laws in place to take the same responsible look at how flower is being cultivated with an eye toward protecting consumers," said Dennis G. Forchic, Chief Executive Officer of Solis Tek.
Mr. Forchic continued, "Having served this industry for nearly a decade, Solis Tek recognizes there is a better way for cultivators to increase yield, protect their crops, enhance their product and ultimately grow healthier plants. This is possible using all-natural products made with organic compounds that are devoid of any banned pesticides, animal by-products, heavy metals, chemicals, or strong odors. These are the types of products that Solis Tek is committed to creating to serve the growing cannabis sector, which is projected to reach $3.7 billion in 2018 in California alone."
"In response to welcomed changes in regulations in various states like that of California and the anticipated tightening of regulations as more states legalize cannabis, our Zelda Horticulture division is developing rigorously tested, all-natural products that provide new and alternative solutions to many of the banned products which have been previously utilized by cannabis cultivators. For example, our first product, Terpenez, provides a safe, effective and regulatory-compliant solution for growers in legal markets both in the U.S. and internationally to enhance their plants' terpene profile," Mr. Forchic added.
Mr. Forchic concluded, "As a response to the new California ban, Solis Tek is aggressively targeting the hydroponic stores in the Golden state, most of which carry our lighting product solutions, that now are replacing banned products on their shelf. Retailers and commercial growers alike have made clear their desire for Solis Tek's products under development, in beta testing, and nearing national launch, all of which contain NONE of the California banned products."
To be added to the Solis Tek email distribution list, please email rel="nofollow">SLTK@kcsa.com with 'SLTK' in the subject line.
About Solis Tek
Solis Tek Inc, parent company of wholly owned subsidiaries Solis Tek Digital Lighting and Zelda Horticulture, is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. In late 2017, Solis Tek introduced Zelda Horticulture, an all-natural, heavy metals free, nutrient line. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, http://solis-tek.com.http://markets.businessinsider.com/...icide-Ban-for-Cannabis-Cultivation-1013590577
[/COLOR]
https://eresearch.fidelity.com/eres...49766-001&provider=MRKTWIRE&product=USPR____&
Top Adult Use and Medical Cannabis Cultivator Significantly Increases Yield with Solis Tek HID Lighting Systems
BY Market Wire
— 8:00 AM ET 01/31/2018
CARSON, CA and LAS VEGAS, NV -- (Marketwired) -- 01/31/18 -- Yield, consistency and quality are the key elements to successful commercial cannabis operations. For one of the nation's leading cannabis cultivators, GB Sciences, integrating Solis Tek ( SLTK
) HID digital lighting systems into their cultivation facility has helped them achieve record yields in their most recent grows.
"Building out a state-of-the-art facility was key to our cultivation strategy, and a large piece of that is making sure you have the right lighting solutions," said
Kevin Kuethe, COO of GB Sciences. "The Solis Tek ( SLTK ) fixtures and lights have enabled us to put our plants on a nutritious 'light diet' that closely mimics sunlight, which has enabled us to increase yield. Our heaviest yields to date are from one of our most popular strains named
Jenny Kush that yielded just over 2 grams per watt of finished, trimmed, cured product ready for retail sale."Kuethe continued, "We currently have 4 bloom rooms in the facility, each of which is approximately 1500 square feet and contains 45 Solis Tek A1 complete lighting fixtures. The facility was built to produce the highest and most consistent quality medical-grade cannabis product for both medical and adult-use markets."
"Solis Tek's ( SLTK
) focus on science is what sets our lighting systems apart," said
Alan Lien, president and co-founder of Solis Tek ( SLTK ). "As the first company to market a light diet which most closely replicates the cycles of the sun as well as developing other key safety regulations in the industry, we understand the needs of commercial cultivation facilities. In the case of GB Sciences, their approach to cultivation is unparalleled and we are proud to be an important part of their cultivation strategy."In a recent third-party study of the top five leading cannabis lighting systems, Solis Tek's (SLTK
) A1 digital lighting fixture proved to have the best light energy and spectrum output, providing the highest intensity light spectrum to the canopy and floor, and a more consistent lighting footprint. The study found that Solis Tek High Intensity Discharge (HID) lights helped commercial growers avoid hotspots, creating a more even canopy, where no one plant grows taller and overshadows other plants. This helps cultivators - hobbyists and commercial growers alike - create the best environment to increase yield.To be added to the Solis Tek ( SLTK
) email distribution list, please email SLTK@kcsa.com with 'SLTK' in the subject line.About GB Sciences, Inc.
GB Sciences, Inc. is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions.
Top Adult Use and Medical Cannabis Cultivator Significantly Increases Yield with Solis Tek HID Lighting Systems
BY Market Wire
— 8:00 AM ET 01/31/2018
CARSON, CA and LAS VEGAS, NV -- (Marketwired) -- 01/31/18 -- Yield, consistency and quality are the key elements to successful commercial cannabis operations. For one of the nation's leading cannabis cultivators, GB Sciences, integrating Solis Tek ( SLTK
) HID digital lighting systems into their cultivation facility has helped them achieve record yields in their most recent grows.
"Building out a state-of-the-art facility was key to our cultivation strategy, and a large piece of that is making sure you have the right lighting solutions," said
Kevin Kuethe, COO of GB Sciences. "The Solis Tek ( SLTK ) fixtures and lights have enabled us to put our plants on a nutritious 'light diet' that closely mimics sunlight, which has enabled us to increase yield. Our heaviest yields to date are from one of our most popular strains named
Jenny Kush that yielded just over 2 grams per watt of finished, trimmed, cured product ready for retail sale."Kuethe continued, "We currently have 4 bloom rooms in the facility, each of which is approximately 1500 square feet and contains 45 Solis Tek A1 complete lighting fixtures. The facility was built to produce the highest and most consistent quality medical-grade cannabis product for both medical and adult-use markets."
"Solis Tek's ( SLTK
) focus on science is what sets our lighting systems apart," said
Alan Lien, president and co-founder of Solis Tek ( SLTK ). "As the first company to market a light diet which most closely replicates the cycles of the sun as well as developing other key safety regulations in the industry, we understand the needs of commercial cultivation facilities. In the case of GB Sciences, their approach to cultivation is unparalleled and we are proud to be an important part of their cultivation strategy."In a recent third-party study of the top five leading cannabis lighting systems, Solis Tek's (SLTK
) A1 digital lighting fixture proved to have the best light energy and spectrum output, providing the highest intensity light spectrum to the canopy and floor, and a more consistent lighting footprint. The study found that Solis Tek High Intensity Discharge (HID) lights helped commercial growers avoid hotspots, creating a more even canopy, where no one plant grows taller and overshadows other plants. This helps cultivators - hobbyists and commercial growers alike - create the best environment to increase yield.To be added to the Solis Tek ( SLTK
) email distribution list, please email SLTK@kcsa.com with 'SLTK' in the subject line.About GB Sciences, Inc.
GB Sciences, Inc. is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions.
